Fogarty Center Mixes Open Talks with Secret Grant Reviews
Published Date: 10/1/2025
Notice
Summary
The Fogarty International Center is holding a hybrid meeting on June 1-2, 2026, where part of it will be closed to review grant applications, and the rest will be open to the public to discuss current and future projects. Researchers applying for grants and the public interested in global health are affected. No registration is needed to join the open session, and special accommodations are available upon request.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Grant Reviews Held in Closed Session
On June 1, 2026 from 3:00 p.m. to 5:00 p.m., the Fogarty International Center will close the meeting to review and evaluate the second level of grant applications. This session is not open to the public because discussions could disclose confidential trade secrets, patentable material, or personal information about applicants.
Open Public Session — No Registration
On June 2, 2026 from 9:00 a.m. to 12:30 p.m., the Fogarty International Center will hold an open session about current and planned activities that any member of the public may attend. Registration is not required and the open session can be accessed from the Fogarty website; special accommodations are available upon request.
On-Campus Visitor Security Requirements
Visitors attending the in-person meeting must follow NIH security procedures, which include vehicle inspections before entry and showing one form of identification (for example, a government-issued photo ID, driver's license, or passport). The NIH security procedures apply to all visitors and are posted at https://security.nih.gov/visitors/Pages/visitor-campus-access.aspx.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2025-19106, Self-Regulatory Organizations; Nasdaq PHLX LLC; Notice of Filing of a Proposed Rule Change To Amend the Amended and Restated Certificate of Incorporation and By-Laws of Its Parent Corporation, Nasdaq, Inc.
Nasdaq PHLX LLC wants to update the official rules and documents of its parent company, Nasdaq, Inc., to match new Delaware laws and modern business practices. These changes affect how Nasdaq runs things but won’t cost extra or change timing for anyone. The SEC is now asking for public feedback before giving the green light.
Next: 2025-19108, Office of the Secretary; Notice of Meeting
The Muscular Dystrophy Coordinating Committee is holding a free online meeting on October 31, 2025, to discuss new research plans and ways to help people living with muscular dystrophy. Government officials, patient groups, and industry leaders will join forces to shape a 10-year action plan. Anyone interested can register to watch, ask questions, and share their thoughts—no cost involved!